Compounds > 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one
Page last updated: 2024-09-02

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and meclonazepam

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one has been researched along with meclonazepam in 1 studies

Compound Research Comparison

Studies
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)		Trials
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)		Recent Studies (post-2010)
(2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one)		Studies
(meclonazepam)		Trials
(meclonazepam)		Recent Studies (post-2010) (meclonazepam)
56023144

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, SJ; Yerbury, RE1

Other Studies

1 other study(ies) available for 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and meclonazepam

ArticleYear
Benzodiazepine-induced hyperphagia: stereospecificity and antagonism by pyrazoloquinolines, CGS 9895 and CGS 9896.
    Psychopharmacology, 1986, Volume: 89, Issue:4

    Topics: Animals; Benzodiazepinones; Clonazepam; Eating; Male; Molecular Conformation; Pyrazoles; Rats; Receptors, GABA-A

1986